The small cell carcinoma neuroendocrine type of the larynx-Case report

This report underscores the need for thorough, systemic diagnostic work-up, and emphasizes that the combination of RT and CHT remains the treatment of choice for ESCCNET (while surgery is reserved for persistent and recurrent disease). In addition, it points out that the new therapeutic strategies to improve survival in ESCCNET are needed, such as a prophylactic cranial irradiation that could be explored in future clinical trials.